Thyrocare Technologies Limited

Thyrocare Technologies Limited (TTL) is a leading Public Limited Indian Non-Government Company incorporated in India on 28 January 2000 and has a history of 23 years and seven months. Its registered office is in Thane, Maharashtra, India.

It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 539871 and on the National Stock Exchange(NSE) under THYROCARE.

The Corporate is engaged in providing diagnostic testing services.

Thyrocare Technologies offers a wide range of products and services, including:

• Medical Surgery & Treatment Centres
• Medical Treatment Services
• Infusion Syringes & Supplies
• Blood Collection Tubes
• Medical Laboratory Instruments
• Blood Bank Equipments
• Flavours & Aromatics
• Food Enzymes
• Towels, Napkins & Handkerchieves
• Tissue Paper

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 100.00 cr and a paid-up capital of Rs 52.93 cr.

The Corporate currently has active open charges totaling ₹45.00 cr. It has already closed loans amounting to ₹4.62 Lakh, as per the Ministry of Corporate Affairs (MCA) records.

The Key Managerial Personnel (KMP) at Thyrocare Technologies Limited India are Alok Jagnani serving as the Chief Financial Officer (CFO), Ramjee Dorai as Company Secretary, and Rahul Guha as the Chief Executive Officer (CEO). Dhaval Shah, Dharmil Sheth, Indumati Gopinathan, and Five other members serve as directors at the Company.